Why the study?
The role of permanent pacemaker implantation after TAVR and SAVR on mid- and long-term outcomes remains controversial, with contradictory published results.
Does permanent pacemaker implantation affect mid- and long-term outcomes in patients undergoing transcatheter or surgical aortic valve replacement?
Does permanent pacemaker implantation affect mid- and long-term outcomes in patients undergoing transcatheter or surgical aortic valve replacement?
The impact of permanent pacemaker implantation on mid- and long-term outcomes after TAVR or SAVR remains controversial and requires further clarification.
Despite advances in technologies and clinical experience, conduction disorders, after transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR), represent the weak point of these procedures, requiring permanent pacemaker implantation (PPI) till 37.7% of patients in TAVR recipients. The role of PPI in TAVR and SAVR remains controversial in mid- and long-term outcomes. Indeed, many studies have been published with contradictory results, leaving doubts rather than certainties.
No takes yet. Share an insight, caveat, or question.
Totaro et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: